![Steven Moss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Moss
Gründer bei Isomerase Therapeutics Ltd.
Aktive Positionen von Steven Moss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | - |
Gründer | 01.01.2012 | - |
Karriereverlauf von Steven Moss
Ehemalige bekannte Positionen von Steven Moss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Corporate Officer/Principal | 05.01.2010 | 12.03.2013 |
Ausbildung von Steven Moss
University of Durham | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Steven Moss
- Erfahrung